Where GLP-1s Fit in the Menopausal Framework Returning to the framework established in the previous section, the menopausal transition represents a disruption operating on two levels: the upstream withdrawal of hormonal signaling, and the downstream metabolic consequences that withdrawal produces
Uric Acid Surprise Notably, there was also a 12% decrease in uric acid associated with the supplement regimen
Thyroid patients typically take thyroid hormone replacement drugs, which fall into three categories: Levothyroxine, a synthetic form of the thyroxine (T4) thyroid hormone Liothyronine, a synthetic form of the triiodothyronine (T3) hormone Natural desiccated thyroid (NDT), a natural drug derived from porcine (pig) thyroid, that contains natural forms of both T4 and T3 Paloma patients receiving hormone replacement therapy (HRT) are frequently prescribed bioidentical medications that provide additional estrogen or progesterone for relief of the symptoms of perimenopause and menopause
From diabetes to longevity Originally developed for type 2 diabetes, GLP-1s are now approved for weight loss and increasingly for other conditions including cardiovascular disease, kidney disease, and sleep apnoea with trials underway for Alzheimers, addiction, and even osteoarthritis
.jpeg)
